C12N 2740/16031
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2740/16031 (Uses of virus other than therapeutic or vaccine) appears on 8 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 13
- Assignees
- 9
- Inventors
- 22
- Latest grant
- 24 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 4 |
| 2016 | 0 | 0 |
| 2017 | 2 | 2 |
| 2018 | 1 | 1 |
| 2019 | 1 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Sindbis control virus24 Jun 2025US 12,338,463 B2LGC Clinical Diagnostics, Inc.
- Hybrid proteins and uses thereof1 Feb 2022US 11,236,363 B2Symvivo Corporation
- Lentiviral protein delivery system for RNA-guided genome editing21 Dec 2021US 11,203,768 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Hybrid proteins and uses thereof8 Oct 2019US 10,435,716 B2Symvivo Corporation
- Nucleic acid vectors and uses thereof4 Sep 2018US 10,066,240 B2Symvivo Corporation
- Affinity-based multiplexing for live-cell monitoring of complex cell populations21 Jul 2022US 2022/0228168 A1Massachusetts Institute of Technology
- Sindbis control virus19 Aug 2021US 2021/0254020 A1Seracare Life Sciences, Inc.
- Hybrid proteins and uses thereof12 Dec 2019US 2019/0376092 A1Symvivo Corporation
- Sindbis control virus3 Jan 2019US 2019/0002838 A1Seracare Life Sciences, Inc.
- Lentiviral protein delivery system for rna-guided genome editing9 Aug 2018US 2018/0223313 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents